Empresa Myovant Sciences Ltd.
Acciones
MYOV
BMG637AM1024
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 579
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Director/Board Member | 59 | 22/10/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 97 235 316 | 46 097 791 ( 47,41 %) | 0 | 47,41 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+67,53 % | 63,85 mil M | |
-0,77 % | 41,83 mil M | |
+45,66 % | 40,65 mil M | |
-10,72 % | 27,12 mil M | |
+13,30 % | 26,52 mil M | |
-22,79 % | 18,69 mil M | |
+4,70 % | 12,73 mil M | |
+24,10 % | 12,11 mil M | |
+27,41 % | 12,07 mil M |